Woman who loves God, my family, & my country, as well as Freedom lovers worldwide. Not here for followers. #FamilyIsEverything #GodWins
Researchers from Duke University School of Medicine have developed a potential new drug, HS-291, which can destroy the Lyme disease-causing bacteria Borrelia burgdorferi. It does this by targeting and inhibiting a specific type of enzyme within the bacteria. The researchers hope their discovery will help patients suffering from persistent and widespread symptoms to find relief.
This novel and selective treatment was inspired by research that targets cancer tumors and was partially funded by Project Lyme, in partnership with the Bay Area Lyme Foundation.
Learn more: https://projectlyme.org/novel-therapy-destroys-lyme-in-lab/
#projectlyme#Lyme#tickbornediseases#lymediseaseawareness#chronicillness#Chronicpain#Health#tickbite#medicine#science#research
Novel Therapy Destroys Lyme In Lab - Project Lyme
Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases. This project was partially funded by Project Lyme, in partnership with the Bay Area Lyme Foundation.
https://projectlyme.org/novel-therapy-destroys-lyme-in-lab/
More on HtpG, the enzyme that HS 291 inhibits to kill lyme
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595432/
Interactions of Escherichia coli molecular chaperone HtpG with DnaA replication initiator DNA - PMC
The bacterial chaperone high-temperature protein G (HtpG), a member of the Hsp90 protein family, is involved in the protection of cells against a variety of environmental stresses. The ability of HtpG to form complexes with other bacterial proteins, ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595432/
